XP0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Xenon Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 46.2 EUR -1.28%

Market Cap: €3.5B

X	Xenon Pharmaceuticals Inc F:XP0	CA
	Azimut Holding SpA MIL:AZM	IT
	Copernico SIM SpA MIL:COP	IT
	Orix Corp NYSE:IX	JP
	Oryzon Genomics SA MAD:ORY	ES
	Ai-Media Technologies Ltd ASX:AIM	AU
	Butterfly Network Inc NYSE:BFLY	US
	Aurania Resources Ltd XTSX:ARU	CA
	Almirall SA MAD:ALM	ES
	Akwel SA PAR:AKW	FR

Profitability Summary

Xenon Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-4 974%

Negative 3Y Average Operating Margin

-32 169%

Operating Margin is Increasing

-24 004% > -4 974%

Negative Net Margin

-4 612%

Negative 3Y Average Net Margin

-28 339%

Net Margin is Increasing

-21 997% > -4 612%

Negative Free Cash Flow Margin

-3 732%

Negative 3Y Average Free Cash Flow Margin

-23 696%

Free Cash Flow Margin is Increasing

-17 806% > -3 732%

Negative ROE

-52%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-173%

Declining ROIC

-163% > -304%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.